Table 2.
Cell Populations | Specific Cluster Name 1 | Organism | Tissue | Cell Source | Gene Marker 2 | Reference |
---|---|---|---|---|---|---|
ILCP | ALP | Mouse | BM of Tcf7EGFP mice | Lin−cKit+2B4+α4β7−Flt3hiIL-7Rα+ | Tcf7 Flt3 H2dma Sp1 Mef2c | [198] |
sEILP | BM of Tcf7EGFP mice | Lin−cKit+2B4+α4β7+Tcf7-GFP+ | Tcf7 Irf8 Runx3 | [198] | ||
cEILP | BM of Tcf7EGFPmice | Lin−cKit+2B4+α4β7+Tcf7-GFP+ | Tcf7 Runx3 Tox | [198] | ||
General | BM of Tcf7EGFP mice | Lin−cKit+2B4+α4β7+Tcf7-GFP+ | Zbtb16 Lmo4 Rora | [198] | ||
General | BM | Lin−Flt3lo/−IL−7Rαlo/+α4β7+ | Zbtb16 Il7r Kit Itga4 Itgb7 but low Myc | [199] | ||
General | BM | Lin−Flt3lo/−IL−7Rαlo/+α4β7+ | Tcf7 Il18r1 | [199] | ||
ILC1 | General | Mouse | Colon-tumor-infiltrating ILCs | CD45+Lin−CD127+ | Xcl1 Tbx21 Klrb1c Ncr1 Ifng Klrd Klrk1 Klrc1 Ctsw | [138] |
ILC1s and/or cNKs | BM | Lin−Flt3lo/−IL−7Rαlo/+α4β7+ | Cish | [199] | ||
Bile duct-ILC1 | Liver or EHDB after Il-33 | CD45+Lin− | Cd28 Il12rb2 Thy1 Cd93 Tbx21 Ifngr1 Il2 Il10 | [200] | ||
General | Salmonella-infected ceca of WT or Rorasg/sg BM-transplanted (BMT) chimeric mice | CD45.2+Lin−CD90+ | Xcl1 | [201] | ||
General | Human | Tonsil | Lin−CD127+NKG2A−CD16−CD117−CRTH2− | CXCR3 IFNG | [202] | |
General | CRC tissue | Lin−CD45+CD127+ | CD3D CD3G CCL4 IFNG IKZF3 PRDM1 | [203] | ||
General | Lung, blood, colon and tonsil | Lin−CD45+CD127+CD117−CRTH2− | IL7R | [204] | ||
General | PB | Lin−CD45+CD127+CD117−CRTH2− | ETS1 TBX21 EOMES IFNG BCL11BTCF7 | [205] | ||
ILC2 | General | Mouse | BM | Lin−Flt3lo/−IL-7Rαlo/+α4β7+ | Pdcd1 Bcl11b Icos Rora Gata3 | [199] |
General (from clusters c8 to c10) | BM | Lin−Flt3lo/−IL-7Rαlo/+α4β7+ | Il2ra Il1rl1 Bmp7 Pparg | [199] | ||
General (cluster c8) | BM | Lin−Flt3lo/−IL-7Rαlo/+α4β7+ | Itgb3 Pbxip1 1700113H08Rik | [199] | ||
General (cluster c9) | BM | Lin−Flt3lo/−IL-7Rαlo/+α4β7+ | Ccr8 Gclc | [199] | ||
General | Colon tumor infiltrating ILCs | Lin−CD45+CD127+ | Gata3 Il4 Il5 Klrg1 Il1rl1 Il13 Il17rb Fosb Hes1 Itga4 | [138] | ||
Liver-specific ILC2 | Liver or EHDB after Il-33 | CD45+Lin− | Ccr4 Tnfsf9 Il12rb1 IL10 NFil3 Idi1 IL9r | [200] | ||
Canonical ILC2 | Liver or EHDB after Il-33 | CD45+Lin− | Rora Gata3 Arg1 Ccr8 Klrg1 Icos Il17Rb Ccr2 Il5 Il13 | [200] | ||
General | Adult and neonatal lung | CD45lo/+Linlo RORγt−YFP−YFP+ | Areg Il7r Rora and Gata3 and the lack of expression of stromal NK/ILC1 B and T cell genes | [206] | ||
Conventional ILC2 | Adult and neonatal lung | CD45lo/+Linlo RORγt−YFP−YFP+ | Il1rl1 Tnfrsf18 Areg and Arg1 | [206] | ||
General | Adult and neonatal lung | CD45lo/+LinloRORγt−YFP−and YFP+ | Cd7 Runx3 Cd2 Tcf7 Il18r1 | [206] | ||
ILC2 mature | Infected lung | (Lin−) CD45+Il7ra+Thy1+/lowNK1.1− | Gata3 Il1rl1 Klrg1 Bcl11b | [207] | ||
ILC2 effector | Infected lung | (Lin−) CD45+Il7ra+Thy1+/lowNK1.1− | Il5 Il13 Il17a | [207] | ||
Natural ILC2 | Lung | Lin−CD3−TCRβ−Thy1+ | Cd69 Nfkbid Fos Il13 Il1r2 Cxcl3 Calca Cxcl2 Il5 Csf2 Ccl1 | [208] | ||
Inflammatory ILC2 | Lung | Lin−CD3−TCRβ−Thy1+ | Gzma Lgals1 Stmn1 Ccr9 Lgals3 Klrg1 | [208] | ||
General | Salmonella-infected ceca of WT or Rorasg/sg BM-transplanted (BMT) chimeric mice | CD45.2+Lin2CD90+ | Gata3 Il4 Il17rb Il1rl1 Rora Il7r | [201] | ||
General | Human | Lung, blood, colon and tonsil | CD3−CD4−Lin−CD45+CD127+CD117+/−CRTH2+ | IL7R GATA3 MAF PTGRD2 HPGDS | [204] | |
c-kit- ILC2 | Skin | CD45+Lin−CD127+CRTH2+CD117−/+ | GATA3 CRLF2 IL17RB CCR6 RORA BCL11B | [205] | ||
c-kit+ ILC2 | Skin | CD45+Lin−CD127+CRTH2+CD117−/+ | CRLF2 IL17RB CCR6 RORA BCL11B ZBTB16 RORC | [205] | ||
General | Tonsil | Lin−CD127+NKG2A−CD16−CRTH2+ | GATA3 IL1RL1 IL17RB PTGDR2 | [202] | ||
ILC3 | General | Mouse | BM | Lin−Flt3lo/−IL-7Rαlo/+α4β7+ | Tbx21 Il2rb Ncr1 Cxcr3 Ctsw | [199] |
General | Colon-tumor-infiltrating ILCs | Lin−CD45+CD127+ | Rorc Il22 Ncr1 Sepp1 Ccr7 Fcer1g Cd74 | [138] | ||
ILCreg | Colon-tumor-infiltrating ILCs | Lin−CD45+CD127+ | Id3-Il10-Ctla4-Klf2-Tnfrsf18-Tnfrs8-Tnfrs9 | [138] | ||
General | Salmonella-infected ceca of WT or Rorasg/sg BM-transplanted (BMT) chimeric mice | CD45.2+Lin2CD90+ | Rora Il7r Thy1 Gzmb Xcl1 Ncr1 Ifng Cxcr6 Cd4 | [201] | ||
General | Human | Lung, blood, colon and tonsil | CD45+Lin−CD127+CD117+CRTH2− | KIT IL1R1 IL23R RORC | [204] | |
General | Tonsil | expression of NKp44 CD62L HLA-DR | IL1R1 IL23R RORC AHR NCR2 | [202] | ||
NK | mNK | Mouse | Blood | CD3−CD19−CD45.2NK1.1+NKp46+ | Hbb-bs Smad7 Tgfb1 Qrfp Ifngr1 | [209] |
mNK_Bl1 | Blood | CD3−CD19−CD45.2NK1.1+NKp46+ | Gzmb Klrg1 Ly6c2 Cma1 Klra9 Ncr1 Emp3 Fgl2 | [209] | ||
mNK_Bl2 | Blood | CD3−CD19−CD45.2NK1.1+NKp46+ | Ctla2a Emb Ccr2 Socs3 Xlc1 Cd27 Cd7 Ltb | [209] | ||
General | Blood | CD45+Lin−NK1.1+NKp46+ | Ly6c2 Klrg1 Klra4 | [210] | ||
NK (non-tissue- specific) | Blood, spleen, inguinal lymph node, liver, VAT, small intestine IEL/LPL, salivary gland and uterus | CD45+Lin−NK1.1+NKp46+ | Itgam S1pr5 Cma1 Zeb2 | [210] | ||
General | Inguinal lymph node | CD45+Lin−NK1.1+NKp46+ | Il7r Ly6c2 Klra8 Klra4 Il18r1 | [210] | ||
General | Liver | CD45+Lin−NK1.1+NKp46+ | Itga1 | [210] | ||
NK (tissue-specific) | Liver, VAT, salivary gland, uterus, small intestine IEL/LPL and tumor | CD45+Lin−NK1.1+NKp46+ | Kit Itga1 Cd160 Asb2 S100a4m Fgl2 Gzmb Cd7m Ctla2 CCr2 Itgb1 Capg Tnfrsf9 Anxa2 Ldha Irf8 | [210] | ||
NK (early Pec) | Peritoneal exudates | CD3ε−NKp46+CD49b+ | Furin Ctla2a, Ifitm1 Ifng | [211] | ||
NK (late Pec) | Peritoneal exudates | CD3ε−NKp46+CD49b+ | Spp1 Gzmb Lag3 Ly6a | [211] | ||
General | Salivary gland and uterus | CD45+Lin−NK1.1+NKp46+ | Klra4 Klra8 Itga1 Il7r | [210] | ||
General | Salmonella-infected ceca of WT or Rorasg/sg BM-transplanted (BMT) chimeric mice | CD45.2+Lin2CD90+ | Ncr1 Sell Eomes Gzma | [201] | ||
General | Small-intestine IEL/LPL | CD45+Lin−NK1.1+NKp46+ | Kit Itga1 Il7r | [210] | ||
mNK | Spleen | CD3−CD19−CD45.2NK1.1+NKp46+ | Jun Ccl3 Fos Ccl4 Fosb Klf2 | [209] | ||
mNK_Sp1 | Spleen | CD3−CD19−CD45.2NK1.1+NKp46+ | Lgals1 Cma1 Gzmb Fgl2 Klra9 Lys6c2 Irf8 Klrg1 | [209] | ||
mNK_Sp2 | Spleen | CD3−CD19−CD45.2NK1.1+NKp46+ | Ctla2a Ltb Emb Cd28 Xcl1 Cd7 Spry2 Fosb Cd27 Cebpb | [209] | ||
mNK_Sp3 | Spleen | CD3−CD19−CD45.2NK1.1+NKp46+ | Nfkbia Nr4a1 Pim1 Prr7 Ccl4 | [209] | ||
General | Spleen | CD45+Lin−NK1.1+NKp46+ | Ly6c2 Klrg1 Klra4 Klra8 Il18r1 | [210] | ||
General | Spleen | CD3−CD19−NK1.1+NKp46+Eomes-GFP+CD49a− | Eomes Itgam Zeb2 (no expression of Cd27 Itga1) | [212] | ||
NK (early Spl) | Spleen | CD3ε−NKp46+CD49b+ | Xcl1 Ncr1 Jun Fos | [211] | ||
NK (resting Spl) | Spleen | CD3ε−NKp46+CD49b+ | Cma1 Klf2 Zeb2 Itga4 Klrc2 | [211] | ||
NK (proliferating Pec/Spl) | Spleen/peritoneal exudates | CD3ε−NKp46+CD49b+ | Mki67 Top2a Stmn1 | [211] | ||
Cd11bˡᵒʷCd27ʰᶦᵍʰ | TME | CD3ε−NK1.1+ | Kit Pdcd1 Tigit Ctla4 | [213] | ||
Cd11bʰᶦᵍʰCd27ˡᵒʷ | TME | CD3ε−NK1.1+ | Klrg1 Ncr1 Klrb1c Itga2 Klra3 Klra9 Prf1 Gzma Gzmb | [213] | ||
NK(Hif1a−/−) | TME | CD3ε−NK1.1+ | Ifng Cd69 Ccl4 Ccl3 Nr4a1 | [213] | ||
General | VAT | CD45+Lin−NK1.1+NKp46+ | Itga1 Il7r Ly6c2 | [210] | ||
hNK | Human | Blood | CD3−CD14−CD19−CD45+CD56low/+ | PTMA S100A6 TGFB1 GNLY LDHA SCL75A | [209] | |
hNK_Bl1 | Blood | anti-CD3, -CD14, -CD19, -CD45, -CD56 | FGFBP2 GZMB GZMA SPON2 CST7 FGCR3A GTF3C1 | [209] | ||
hNK_Bl2 | Blood | anti-CD3, -CD14, -CD19, -CD45, -CD56 | GZMK CD44 CXCR3 SCML1 NCF1 XCL1 SCML1 ZFP36L2 | [209] | ||
General | Blood | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | GZMK JUNB LTB LNFS | [214] | ||
bNK0 | Blood | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | FCGR3A FCGR3B PRF1 GZMB | [214] | ||
bNK1 | Blood | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | GZMK SELL | [214] | ||
bNK2 | Blood | CD45+CD56+CD3ε−CD4−CD8a−CD14–CD15−CD163− | SELL IL7R XCL1/2 | [214] | ||
bNK3 | Blood | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | PCNA MKI67 | [214] | ||
h_NK_Bm1 | BM | CD3−CD14−CD19−CD45+CD56low/+ | FGFBP2 GZMB GZMH PRF1 FCGR3A | [215] | ||
h_NK_Bm2 | BM | CD3−CD14−CD19−CD45+CD56low/+ | CCL3 CCL4 XCL1 XCL2 GZMK CCL3L1 AREG CD160 CD69 | [215] | ||
h_NK_Bm3 | BM | CD3−CD14−CD19−CD45+CD56low/+ | GZMK XCL1 XCL2 AREG LTB SELL CD44 | [215] | ||
h_NK_Bm4 | BM | CD3−CD14−CD19−CD45+CD56low/+ | CCL5 GZMM GZMH ZEB2 | [215] | ||
General | BM | Not provided | GZMH GZMK GNLY | [216] | ||
General | Bronchoalveolar lavage fluid | Not provided | TYROBP KLRD1 NKG7 FCER1G GNLY PRF1 GZMB KLRF1 XCL1/2 CCL3/4 | [217] | ||
General | Liver/cirrhotic liver | CD45+ | KLRF1 CCL3 XCL1 IL2RB XCL2 CD160 KDLR1 CLEBPD CLIC3 LAT2 CCL3L3 | [218] | ||
cNK | Liver/cirrhotic liver | CD45+ | KLRF1 GNLY PRF1 FGFBP3 SPON2 | [218] | ||
General | Liver | Viable cells | NKG7 CCL4 CCL5 KLRD1 KLRK1 GZMA GZMB GZMH | [219] | ||
General | Liver | Viable cells | CD7 KLRB1 NKG7 | [220] | ||
trNK | Liver | CD45+ | KLRB1 TRDC CXCR6 EOMES GZMK KLRF1 | [221] | ||
cNK | Liver | CD45+ | TBX21 CX3CR1 GZMB TRDC FGCR3A KLRF1 | [221] | ||
NK-GZMH | Intrahepatic cholangiocarcinoma | Viable cells | KLRF1 KLRB1 IL7R LTB CCR6 NCR3 | [222] | ||
NK-GZMK | Intrahepatic cholangiocarcinoma | Viable cells | KLRF1 TYROBP FCER1G GZMK CD160 | [222] | ||
General | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15CD163− | FGFBP2 FCGR3A PRF1 S1PR5 GZMB | [214] | ||
tNK0 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | AREG SELL XCL1/2 FOS | [214] | ||
tNK1 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | CCL3/4L2/5 CD160 TIGIT | [214] | ||
tNK2 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | FGFBP2 FGCR3A PRF1 GZMB | [214] | ||
tNK3 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | SELL SPTSSB KIR2DL4 | [214] | ||
tNK4 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD16− | LST1 LTB | [214] | ||
tNK5 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | CCL5 HLA-DRBA GZMH | [214] | ||
tNK6 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | PCNA MKI67 | [214] | ||
tNK7 | Melanoma metastasis | CD45+CD56+CD3ε−CD4−CD8a−CD14−CD15−CD163− | ISG15 IFI6 | [214] | ||
General | Ovarian cancer ascites | CD45+ | KLRB1 KLRF1 | [223] | ||
General | Ovarian cancer ascites | CD45+ | FCGR3A FCGR3B NCAM1 KLRB1 KLRB1 KLRC1 KLRD1 KLRF1 KLRK1 | [224] | ||
General | PBMC | Not provided | KLRF1 FCGR3A | [225] | ||
General | PBMC | Not provided | FCGR3A NCAM1 GZMB | [226] | ||
General | PBMC | Not provided | KLRF1 | [227] | ||
hNK | Spleen | CD3−CD14−CD19−CD45+CD56low/+ | KLF6 NFKBIA TSC22D3 ADGRE5 NCL1 CD69 ANXA1 | [209] | ||
hNK_Sp1 | Spleen | CD3−CD14−CD19−CD45+CD56low/+ | FGFBP2 GZMB CST7 FGCR3A MYOM2 GNLY S100A4 CYBA PRF1 | [209] | ||
hNK_Sp2 | Spleen | CD3−CD14−CD19−CD45+CD56low/+ | GZMK XCL1 COTL1 CD160 TOX2 RGS1 LIF KLRB1 KLRB1 BCL2A1 SPRY2 | [209] | ||
hNK_Sp3 | Spleen | CD3−CD14−CD19−CD45+CD56low/+ | IL7R DUSP4 CD52 GRP183 SELL CD44 CAPG LTB YBX3 | [209] | ||
hNK_Sp4 | Spleen | CD3−CD14−CD19−CD45+CD56low/+ | TTC30B TXNIP ARRDC3 SDF2 INPP5F | [209] | ||
General | Tonsil | CD45+Lin−CD127−CD56+NKG2A+ | KLRC1 GNLY GZMA EOMES | [202] | ||
General | TME/PBMC | CD3CD4CD8CD25 | CD160 XCL1 XCL2 MYADAM CAPG RORA NR4A1/2/3 KLRC1/2/3 IKZF2 EDNTPD1 CD69 ITGAE | [228] | ||
NK-1 | Tumor/blood | CD3CD19CD20− | IFIT1/3 IFI6 CD8a | [229] | ||
CD14−CD34−CD68−CD56+/−CD127+/− | ||||||
NK-2 | Tumor/blood | CD3−CD19−CD20−CD14−CD34−CD68−CD56+/−CD127+/− | NR4A2 REL CXCR4 | [229] | ||
NK-ILC1 | Tumor/blood | CD3−CD19−CD20−CD14−CD34−CD68−CD56+/−CD127+/− | CD83 IL7R SELL | [229] |
1 When provided and different from cell population (general). 2 Selected on the basis of the relevance in the study.